Table 1.

Baseline characteristics of patients randomized to CsA

Baseline FactorAll Randomized(n = 72)Patients in This Substudy (A) (n = 22)Patients not in This Substudy (B) (n = 50)P Value (A) versus (B)
Age at Enrollment (yr)15 (4–34)15 (7–34)15 (2.5–32)0.52
White race40 (55.6)15 (68.2)25 (50.0)0.47
Male sex40 (55.6)13 (59.1)27 (54.0)0.80
Baseline GFR (ml/min per 1.73m2)136.6 ± 79.0126.8 ± 50.5140.9 ± 88.80.49
UP/C (mg/mg)4.4 (1.2–13.3)2.7 (1.1–5.1)5.4 (1.3–15.4)0.002
Serum Albumin (g/d)3.0 (1.7–4.1)3.5 (2.6–4.2)2.6 (1.6–4.0)0.003
Serum Cholesterol (mg/dl)283 (203–571)259 (163–354)318 (233–597)0.01
Hypertensive41 (56.9)13 (59.1)28 (56.0)1.00
  • Data shown as median (10th–90th percentile), n (%), or mean ± SD. CsA, cyclosporin A; UP/C, urinary protein/creatinine ratio.